Evidence map›Paper›PMID 24292151›Full record

ArticleNature communications2013

Discovery of chlamydial peptidoglycan reveals bacteria with murein sacculi but without FtsZ.

Martin Pilhofer, Karin Aistleitner, Jacob Biboy, Joe Gray, Erkin Kuru, Edward Hall, Yves V Brun, Michael S VanNieuwenhze, Waldemar Vollmer, Matthias Horn and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Infection and immunity · 2026
    Article
  3. Peptidoglycan polymerase function and regulation.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Journal of bacteriology · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Frontiers in microbiology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Localized Peptidoglycan Biosynthesis inFrontiers in microbiology · 2021
    Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Martin Pilhofer *Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
Karin Aistleitner *Division of Microbial Ecology, University of Vienna, Vienna, A-1090, Austria.
Jacob BiboyInstitute for Cell and Molecular Biosciences, The Centre for Bacterial Cell Biology, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom.
Joe GrayInstitute for Cell and Molecular Biosciences, Pinnacle Laboratory, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom.
Erkin KuruIndiana University, Bloomington, IN, 47405, USA.
Edward HallIndiana University, Bloomington, IN, 47405, USA.
Yves V BrunIndiana University, Bloomington, IN, 47405, USA.
Michael S VanNieuwenhzeIndiana University, Bloomington, IN, 47405, USA.
Waldemar VollmerInstitute for Cell and Molecular Biosciences, The Centre for Bacterial Cell Biology, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom.
Matthias HornDivision of Microbial Ecology, University of Vienna, Vienna, A-1090, Austria.
Grant J JensenDivision of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
Indiana University Bloomington · USUniversity of Vienna · ATCalifornia Institute of Technology · USHoward Hughes Medical Institute · US

Funding

GLOBAL CONTROL OF DIFFERENTIATION IN CAULOBACTERR01GM051986 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BRUN, YVES V · 1995 to 2016
$6.0M
Structure and function of the prokaryotic cytoskeleton by electron cryotomographyR01GM094800 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI JENSEN, GRANT J · 2011 to 2015
$1.7M
Synthesis and Mechanistic Studies of Peptide AntibioticsR01AI059327 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VANNIEUWENHZE, MICHAEL S · 2005 to 2009
$1.5M
Synthesis and Mechanistic Studies of Peptide AntibioticsR21AI059327 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI VANNIEUWENHZE, MICHAEL S · 2004 to 2004
$352k
Biotechnology and Biological Sciences Research Council BB/I020012/1European Research Council 281633NIAID NIH HHS AI059327NIAID NIH HHS R01 AI059327NIAID NIH HHS R21 AI059327NIGMS NIH HHS GM051986NIGMS NIH HHS GM094800BNIGMS NIH HHS R01 GM051986NIGMS NIH HHS R01 GM094800
6 · The paper itself

Abstract

Chlamydiae are important pathogens and symbionts with unique cell biological features. They lack the cell-division protein FtsZ, and the existence of peptidoglycan (PG) in their cell wall has been highly controversial. FtsZ and PG together function in orchestrating cell division and maintaining cell shape in almost all other bacteria. Using electron cryotomography, mass spectrometry and fluorescent labelling dyes, here we show that some environmental chlamydiae have cell wall sacculi consisting of a novel PG type. Treatment with fosfomycin (a PG synthesis inhibitor) leads to lower infection rates and aberrant cell shapes, suggesting that PG synthesis is crucial for the chlamydial life cycle. Our findings demonstrate for the first time the presence of PG in a member of the Chlamydiae. They also present a unique example of a bacterium with a PG sacculus but without FtsZ, challenging the current hypothesis that it is the absence of a cell wall that renders FtsZ non-essential.

Indexed as

Bacterial ProteinsCell WallChlamydialesCytoskeletal ProteinsPeptidoglycanBacterial ProteinsCytoskeletal ProteinsFtsZ protein, BacteriaPeptidoglycan

Identifiers

PMID24292151
PMCPMC3847603
OpenAlexW1989717746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.